Retention Focus for Sports Betting Brands after Super Bowl LVI

by

Share

Keeping customers active to prevent attrition is key to growth

Gzira, Malta – February 10, 2022 – With the number of U.S. states legalizing online sports betting growing at a fast pace over the last year, online gambling brands will be keen to attract new players ahead of Super Bowl LVI on February 14th. However, customer service experts Enteractive say that retention of new players will be key to maintaining growth in the current gold rush to build a loyal customer base.

“While sportsbook operators are spending large sums on licensing, promotion, marketing, and competitive odds to prompt fast growth as they enter these new markets in the U.S., they must keep a focus on retention of all those hard-won customers,” says Mikael Hansson, founder of Enteractive, a company which provides loyalty and engagement services for the online gambling industry, contacting players on behalf of sports betting brands with more personal one-to-one phone calls.

Following last month’s successful launch of mobile sports gambling services in New York, it’s clear that there’s a large appetite amongst US consumers for the growing number of online sportsbooks. In a YouGov survey from January 2021, almost 20% of Americans said they like to wager on the Super Bowl, with 77% betting purely on the outcome of the game.

In 2022, with so many more states now offering legalized mobile sports betting, sportsbook operators can expect to see increased registrations from new customers around Super Bowl LVI, but while this increased interest is good for business, successful growth will depend upon those new customers remaining active, rather than ‘churning’ after big events like the Super Bowl are over.

“There’s currently a gold rush in the U.S. sports betting market,” adds Hansson, “and the eventual winners will be those brands that engage with their customers and build relationships for the future. Every brand in this sector must keep a clear focus on all aspects of their offering, ensuring that all the hard work in getting to market is not quickly lost to the competition.”

Share

Ei.Ventures and Orthogonal Thinker Acquire 12×12 Estate in The Sandbox in Anticipation of PSLY.COM Launch Post-Merger with Mycotopia Therapies in Q1 2022

by

Share

Miami, Florida – January 4, 2022 – Ei.Ventures, along with Orthogonal Thinker, is excited to announce the acquisition of a 12×12 estate in The Sandbox, a virtual world where players can build, own, and monetize their gaming experiences on the Ethereum blockchain. This purchase represents the third-largest land sale in the Metaverse and is valued at $2.22M. The land will be called PSLY.COM, the name of the soon-to-be merged company of Ei.Ventures with Mycotopia Therapies.

After only a week on the platform, Ei.Ventures and Orthogonal Thinker CEO David Nikzad was ready to invest in a legacy project for the combined companies’ vision of psychedelic therapy and move into the Metaverse over the next 36 months, noting, “The combination of our tech, cannabis, psychedelics, outer space, and crypto-related holdings will all be utilizing this exciting space. We are very excited to invite all of our portfolio companies and investors to be part of something extraordinary.”

Ei.Ventures now owns 144 pieces of Sandbox land that make up this 12×12 estate. Their neighbors include noted companies like Axie Infinity, SANDBOX, Binance, and many others. PSLY.COM is now right in the middle of these disruptive giants.

While the exact plans for the PSLY.COM Sandbox space are still in development, expect wondrous VR experiences of Hawaii, positive psychedelic trips, healing modalities, and much more.

Nikzad adds, “As I remember my early days as an investor going to Y Combinator, it was about looking at things that were 10B disruptive. Health and Wellness is a trillion-dollar market. As we’ve now gone through COVID and are still in the craziness of it, these technologies will become much more important as communications and how financial transactions are handled is changing,” and ends with thanks to “Blockchain.com, MetaMask, NFTTRADER, and all the individuals and teams, including Ei’s co-founders, that came together to execute this transaction.”

Mycotopia CEO Benjamin Kaplan adds, “as we are working to close our merger with Ei.Ventures, we are so heartened by the forward-thinking moves Ei is making to set up PSLY.COM for success in the Metaverse and beyond.”

Share

Ei.Ventures Closes Out an Exciting 2021, Heads into 2022 Leading the Way in Psychedelic Medicine Development, Fundraising and more

by

Share

Miami, Florida – December 15, 2021 – First and foremost the Ei.Ventures’ Reg A+ raise has been incredible. Support from investors from all over the country has topped expectations. As it stands, Ei.Ventures has raised $19,914,863 of a $50 million qualification.

With new studies emerging showing that microdosing psychedelics has a clear association with fewer symptoms of depression, anxiety, and stress, it’s no wonder there is such a desire to see Ei.Ventures’ Psilly and other psychedelic medicines hit the mainstream.

And as of last week Ei.Ventures announced some exciting news regarding its Go Public pathway: the company signed an LOI with Mycotopia (TPIA) to explore a merger and the formation of PSLY.COM, a $360 million transaction, and will apply to list shares on NASDAQ. More info about the potential merger and anticipated NASDAQ listing is available here. Ei.Ventures CEO David Nikzad notes, “This is a very exciting deal that provides more certainty in a “Go Public” path forward and disrupts the typical investment-banker run going-public model which is often full of bumps and headwinds. Ei.Ventures anticipates closing on the merger in March 2022, assuming we reach a definitive agreement.”

Part of Ei.Ventures’ business strategy has been to develop revenue producing products and partnerships while the novel psychedelic medicines move down the clinical pathway and into legal jurisdictions. On that front the company has been working on three key partnerships over the past few months.

The first joint venture partnership is with The3RDBevCo out of New York. The3RDBevCo is focused on creating first to market functional beverages into the $110 billion global functional drink market. The3RDBevCo will produce the Psilli line of functional mushroom drinks. Psilli will come in five unique blends that target energy, immune support, sleep, cognition, and mood. Interested beverage and mushroom fans can register to win a lifetime supply on launch in late Q1 of 2022 and learn more about Psilli here.

Ei.Ventures also made progress on the clinical development front, with an engagement with Tioga Labs, a premier transdermal research and development company with US offices in San Diego, a noted biotech hub. Tioga has secured the required DEA credentials to handle psychedelic drugs, and has acquired the raw materials to begin development and testing of a transdermal delivery system. Forbes covered the engagement here.

In conjunction with the development of this novel transdermal formulation, Ei.Ventures has also signed a non-binding LOI with RYAH, a connected device, big data, and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. RYAH has developed a smart patch technology that would further enhance the transdermal delivery system.
The proposed collaboration is expected to:

  • Assess the compatibility of the RYAH Smart Patch delivery and monitoring device, software, and data platform with Ei.Ventures’ proprietary psychedelic formulations
  • Further Ei.Ventures’ research and development strategy, accelerating use testing on controlled delivery and monitoring of psychoactive compounds for mental wellness treatments
  • Position the companies toward a commercial licensing arrangement to deliver psychedelic therapies, in anticipation of governmentally approved treatment options for mental healthcare

There is more info about the LOI here.

In addition to these, Ei.Ventures is working on finalizing an additional partnership with a biotech company focused on developing novel bio synthetic psychedelic materials. This would allow rapid production of botanical psilocin for the current clinical development at an incredibly low cost.

It would also allow pursuit of additional novel patents and IP within the space at a rapid pace. As such Fox Rothschild has been engaged as counsel for further IP development and filings.

The company anticipates that three other very major initiatives will be announced soon.
Ei.Ventures CEO David Nikzad concludes, “As 2021 comes to a close we would like to wish all in the psychedelic, startup, and investment communities, along with our new friends in the South Florida business community, who have been so incredibly welcoming, a wonderful holiday season and a fantastic new year in 2022.”

Share

Ei.Ventures Partners With The3rdBevCo for PSILLI™, a line of Mushroom Infused Functional Sparkling Waters

by

Share

Ronkonkoma, New York/Miami, Florida – November 17, 2021 – Noted medicinal and supplemental mushroom research and development company Ei.Ventures has partnered with rising functional beverage company The3rdBevCo on the first ever line of mushroom infused sparkling waters, called PSILLI™. The line is targeted to be available to wholesalers in late Q1 2022 and to the general public shortly thereafter.

The3rdBevCo CEO Peter Scalise notes, ““I must say meeting the founding team of Ei.Ventures really gives credence to the phrase first impressions are the most important. We immediately hit it off with a working chemistry I never experienced before. We share the same vision, path forward and are laser focused in achieving our goals. Get ready because we are about to bring to market a whole new category in the functional beverage sector unlike anything seen to date that is sure to be the talk of the entire industry from distributors to consumers.”

PSILLI™ is a perfect addition to The3rdBevCo’s growing product range of functional beverages, which include the energy drink line LAID™, CDB energy shot Chill’d™, and ProsecGO™ for those looking for a non-alcoholic experience of Prosecco.

As scientists are discovering, not only are most of the claims about medicinal mushrooms true, but they’re often also safer and better tolerated with fewer side-effects than many modern pharmaceuticals. With PSILLI™, functional mushrooms will be available to
The3rdBevCo’s nationwide base of retailers, bars, restaurants, nightclubs, and event venues, allowing everyone to experience mushrooms’ positive effects.

Functional mushrooms are nutritional powerhouses with a myriad of health benefits including immune support, antioxidants, anti-inflammatory, blood sugar management, brain health and cognition support, nervous system support, and increased energy and stamina.

PSILLI™ will use a variety of mushroom types to create five distinct formulations: Brain Boost to support cognitive and immune function; Study Buddy, a Nootropic supplement; Energizer, a natural energy enhancer; Good Mood a mood optimizer and appetite moderator; and Bedtime, for relaxing.

PSILLI™ will be packaged in the popular 12 ounce slim can and come in five amazing flavors – Black Cherry, Mixed Berry, Blood Orange, Pineapple Hibiscus, Pomegranate Watermelon. With no sugar, zero carbs and only 10 calories in each can, PSILLI™ will be functional and delicious!

Ei.Ventures CEO David Nikzad notes, “We’re so excited to partner with The3rdBevCo on the PSILLI™ line of functional beverages, as they are a leader in the space and can help us spread understanding of the value of mushrooms through the enormous beverage channel. Once people start to use functional mushrooms, they’ll be eager to try the other supplemental mushroom products, and eventually medicinal products that we are bringing to market.”

Share

David Nikzad’s Noted “Utopian Holding Company” Orthogonal Thinker Has Relocated to Miami to Lead for the Future

by

Share

Miami, Florida – November 1, 2021 – Orthogonal Thinker, a self-described “Utopian Holding Company” led by noted investor and exec David Nikzad, is pleased to announce its move to the hottest new venture market – Miami, Florida. This move has invigorated the company, leading to 15 new deals inked since he arrived in early July. Orthogonal makes strategic investments and joint-ventures with companies which contribute to the Orthogonal eco-system of companies in new and emerging industries.

Nikzad, founder and CEO of Orthogonal Thinker notes, “Part of the secret of my success is that I’m just enough ahead of the curve, and my recent move to Miami is just another example of that. We are so excited to be part of the growth of the South Florida startup scene, which is so inclusive of the verticals we specialize in – space, crypto, cannabis, psychedelics, and clean food.”

Orthogonal’s most exciting company is their subsidiary Ei.Ventures. Ei has had an amazing year, cresting $20M committed with their Reg A. As part of their research and development into natural psychedelic compounds, EI recently announced via Forbes that they have partnered with transdermal delivery powerhouse Tioga Research to develop a transdermal patch for sustained delivery of psilocin, the active ingredient in psilocybin mushrooms, for mental health applications.

As part of Ei’s dual track approach, they are planning to launch their line of functional mushroom MANA nutraceuticals imminently, and a functional beverage with mushroom botanicals in early 2022.

Building companies through crowdfunding has always been part of Orthogonal’s DNA, as some early investments included crowdfunders WeFunder, RealCrowd, DealMaker, and Republic. Through this experience and the recent success of Ei’s Reg A, Orthogonal is now positioned as a leader in the Reg A fundraising space and have vertically integrated their internal team to manage Reg A raises for their portfolio companies.

Nikzad adds, “We couldn’t be more bullish on Miami and are looking to show our gratitude for the wonderful reception we’ve gotten in South Florida by bringing funding from all levels of investors to this growing region.”

Share

Emotional Intelligence Ventures Reg A Raise at $20M, Company Pursues Psylocibin Transdermal Delivery Research, Plans Nutraceutical Mushroom Supplements Launch

by

Share

Miami, Florida – October 18, 2021 – Emotional Intelligence Ventures, led by noted investor and exec David Nikzad, are pleased to announce their Regulation A raise is currently at $20,114,949, with more investors coming in daily. Ultimately, they are looking to raise a maximum of $49,999,999, and believe this is a completely doable goal. A Regulation A offering allows for retail investors to invest in pre-public and private companies. The net proceeds of the offering will be used to accelerate the development and distribution of Ei’s medicinal and functional mushroom product lines.

David Nikzad, founder and CEO of Ei.Ventures notes, “We are so committed to the nonaccredited investor, that we are pursuing a Regulation A offering.” Adding, “As I’ve been fortunate to invest early in numerous companies like Airbnb, Betterment, and Vidyard, and three equity crowdfunding platforms (WeFunder, RealCrowd, Republic), I’m really passionate about democratizing investment opportunities so any investor can reap the rewards, and take all of the risks of early investment in game-changing companies.”

As part of their research and development into natural psychedelic compounds, EI recently announced via Forbes that they have partnered with transdermal delivery powerhouse Tioga Research to develop a transdermal patch for sustained delivery of psilocin, the active ingredient in psilocybin mushrooms, for mental health applications.

The company believes this announcement along with the increasing interest in the psychedelic medicine for mental health space, and a rising tide of medicalization, decriminalization, and legalization of psychedelic mushrooms are driving interest in the overall psychedelic medicine space, and Ei.Ventures in particular.

On Monday October 4, the Seattle City Council voted to decriminalize the non-commercial possession and cultivation of many psychedelics, including mushrooms, for “religious, spiritual, healing, or personal growth practices.” Council members passed the resolution unanimously, with a 9-0 vote. This makes Seattle the largest city in the United States to decriminalize psychedelic plants and fungi.

As part of Ei’s dual track approach, they are planning to launch their line of functional mushroom MANA nutraceuticals in early 2022. They are creating proprietary formulations using a unique formulation process for enhanced bioavailability and efficacy. These products target cognition and immune system; energy, vitality, mood, sleep, and weight loss; mental and physical optimization for micro dosers; nootropic or Smart Drugs; and joint & muscle pain.

Share

Ei.Ventures Announce Engagement With Tioga Research to Develop Transdermal Patch for Psilocin Delivery

by

Share

Maui, Hawaii/San Diego, California – August 26, 2021 – Noted psychedelic medicine start-up Ei.Ventures is excited to announce their engagement with Tioga Research to develop a transdermal patch for sustained delivery of psilocin, the active ingredient in psilocybin mushrooms, for mental health applications.

David Nikzad, the CEO of Ei.Ventures notes, “we are over the moon to join with one of the top transdermal delivery research specialists, Tioga Research, to begin developing products that could potentially help millions of people manage their mental health issues – depression, anxiety, PTSD, etc. with a patch. Additionally, with the increasing legality and popularity of psilocybin mushrooms, transdermal delivery could become a popular method for micro-dosing which helps with mental clarity and mood stabilization as well.”

John M. Newsam, CEO of Tioga Research adds, “By working with Ei.Ventures on a blue sky project of this nature, we will deploy our proprietary technologies and deep expertise to address key psilocin formulation issues, such as delivery and stability. A transdermal delivery route can circumvent issues with oral administration, such as nausea.”

EI.Ventures is focused on developing botanical active pharmaceutical ingredients for the psychedelic supply chain, novel psychedelic compounds for various indications, and unique delivery mechanisms and treatment protocols. In addition to their future regulated psychedelic line, Ei Ventures will release their MANA range of functional mushroom nutraceuticals for improving well-being and health in Q3 2021.

Tioga Research supports the research and early development of skin-applied products, offering formulation innovation, skin permeation screening, and GLP IVRT/IVPT services. In addition, the company has pioneered high throughput experimentation (“HTE”) technologies for screening skin delivery. Tioga Research was founded in 2011 to support innovations in skin-applied products, especially topical and transdermal drug products, including skincare products and cosmetics. With headquarters and laboratory operations in San Diego, CA, and a business presence in the UK to support clients in Europe, Tioga Research has become a preferred service provider for an impressive portfolio of clients across the Americas, Europe, and Asia. Tioga Research has been a subsidiary of Encube Ethicals since early 2020, enabling clients to leverage the combined strengths of both organizations from early formulation innovation to commercial manufacturing.

Share

Family Office Portal Launches as Community Hub for over 5000 Family and UHNWI Investment Offices

by

Share

Hosting Family Office/Venture Capital Mixer September 14 at Meat Market Steakhouse Palm Beach

Family Office Portal LogoPalm Beach, Florida – July 29, 2021 – Launching today, Family Office Portal (aka FOPort) sits at the hub of a community comprised of over 5000 ultra-high net worth individual, single, and multi-family offices, the asset managers they work with, service providers, early-stage companies and other members of this unique professional network geared to making the lives of its members easier, more profitable, and more enjoyable.

Family Office Portal curates a network of investors and issuers to connect investors with investment opportunities that match their personal mandates and preferences. Family Offices and UHNWI’s that choose to join this exclusive community are able to view or be directly connected with vetted issuers.
Family Office Portal also partners with best-in-class technology solutions that help family offices in all that they do. Through a range of technologies from basic to incredibly dynamic and complex solutions, FOPort offers the convenience of aggregation and consolidation of these tools, discounted rates, streamlined account management and more. These technologies help family offices with everything from automated and compliant investment processes, and peer to peer due diligence, to enhanced lifestyle experiences, and much more.

Family Office Portal enables members to browse and connect with rare family office sponsored opportunities, the kind that are spoken for before they are public, including early-stage companies that are poised to disrupt industries, or otherwise grow through strategic value add partnerships, investments, etc.

The founders of Family Office Portal are CEO Peter Apostol who has an extensive background working with family offices, alternative investments and lifestyle services. Peter worked with a South Florida based family office packaging and syndicating investments before he began to develop an international family office community. Cecil Robles, FOPort’s VP of Strategy, is an entrepreneur with 17+ years of corporate strategy and global brand-building experience. He has also served as a CMO and CEO and has built and sold multiple businesses in various industries. They are joined by legal advisor Nate Sumbot, who prior to FOPort, was a lawyer with Ballard Spahr LLP, has an extensive background as a securities attorney, and worked as general counsel for the governor’s office of Utah.

Apostol notes, “I founded Family Office Portal as a place to centralize this network with an emphasis on deal flow and other unique opportunities. We are excited to work with families and individuals to access early-stage companies, and to help them invest to fit their personal priorities whether it’s ESG investing, future-proofing their funds, or enabling them to live their passions. And we’re equally excited to bring investment to well vetted young companies that will continue to grow family wealth.”

With events returning, Family Office Portal is excited to host their first 2021 event, a family office/venture capital mixer at the Meat Market Steakhouse 191 Bradley Place, Palm Beach, FL 33480 on September 14 at 5:30 pm. Future events will take place in Miami, Orlando, and Houston, with more to be announced soon. Potential invitees can sign up at https://foport.com/events/.

Share

Emotional Intelligence Ventures Announces Their Qualification of a Regulation A+ Public Stock Offering

by

Share

New York, NY (March 31, 2021) – Emotional Intelligence Ventures (Ei.Ventures or Ei), Inc, the leader in all-natural psychedelic medicine development, today announced that it has been qualified by the Securities and Exchange Commission (SEC) to list a $50 million exempt public stock offering using the Regulation A+ Tier 2 framework. This is only the second public stock offering in the psychedelic medicine space in the U.S. and the first for a company developing products only from all-natural botanical material. A Regulation A+ offering allows for retail investors to invest in pre-public and private companies. The net proceeds of the offering will be used to accelerate the development and distribution of Ei’s medicinal and functional mushroom product lines.

Ei.Ventures is launching this offering as the public needs real access to novel therapies that can reverse, heal, and treat chronic mental health disorders. Ei is the only company poised to bring botanical psychedelic therapies, functional plant medicines, and integrative technology to the market in an acceptable time frame of under 2 years. Due to Covid, lockdowns, and the economic impact of the pandemic, the state of Americans’ mental health has declined significantly over the past year. Ei.Ventures’ solutions need to come to the market as soon as possible and Ei wants to give the retail-investing public a chance to participate in the upside potential of this exciting new field of healthcare.

“While we have raised money with our friends & family and private placement raises, we are so committed to the unaccredited investor, that we’ve engaged with the SEC for a Reg A+,” said David Nikzad, founder and CEO of Ei.Ventures. “As I’ve been fortunate to invest early in numerous companies like Airbnb, Betterment, and Vidyard, and three equity crowdfunding platforms (WeFunder, RealCrowd, Republic), I’m really passionate about democratizing investment opportunities so any investor can reap the rewards, and take all of the risks of early investment in game-changing companies.”

“We believe that this offering may be the first time an all-natural psychedelic medicine project received approval to access the public U.S. markets and we are excited to continue to pursue our capital markets pathway in the U.S. and Canada” Nikzad continued. “This can potentially set a precedent for others in the industry.”

About Ei.Ventures
Empowering mental wellness through psychoactive compounds and technology, Ei.Ventures’ has the largest psychedelic compound library in the world. Our mission is to provide real access to these sacred medicines and compounds to the billion people world-wide suffering from persistent mental health disorders.

Connect with Ei.Ventures: Website | LinkedIn | Twitter

Legend: AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT IS AT: https://www.sec.gov/Archives/edgar/data/1823182/000110465921038430/a20-30556_1partiiandiii.htm YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

Forward Looking Statements: Certain information set forth in this presentation, together with any supplements and any other information that may be furnished to prospective investors by the Company in connection therewith, contains “forward-looking statements” and “forward-looking information” within the meaning of applicable United States securities legislation (referred to herein as forward-looking statements). Except for statements of historical fact, certain information contained herein constitutes forward-looking statements which include but are not limited to statements related to activities, events or developments that Ei.Ventures expects or anticipates will or may occur in the future, statements related to the Company’s business strategy objectives and goals, and management’s assessment of future plans and operations which are based on current internal expectations, estimates, projections ,assumptions and beliefs, which may prove to be incorrect. Forward-looking statements can often be identified by the use of words such as “may”, “will”, “could”, “would”, “anticipate”, ‘believe”, expect”, “intend”, “potential”, “estimate”, “budget”, “scheduled”, “plans”, “planned”, “forecasts”, “goals” and similar expressions or the negatives thereof. Forward-looking statements are neither historical facts nor assurances of future performance. Forward-looking statements are based on a number of factors and assumptions made by management and considered reasonable at the time such information is provided, and forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements.

Share

ICEWIND TURBINE TO POWER EMERGENCY BEACON AT ARCTIC CIRCLE

by

Share

Straumnes Air Station, Westfjords, Iceland (Latitude 66.440607) – October 22, 2020 – Noted wind power startup IceWind is deploying its new Njord series wind turbine just nine miles below the Arctic Circle on the site of the former U.S. Air Force’s Straumnes Air Station in the Westfjords region of Iceland. The air station monitored Soviet maneuvers in the strategic Greenland-Iceland-UK (GIUK) gap during the Cold War. The IceWind RW100 (aka Njord) turbine will power an autonomous emergency beacon operated by the Icelandic Coast Guard (Landhelgisgæsla Íslands) there.

Straumnes is known for its extreme weather. In fact, five prior attempts have been made to run the site on wind energy, all of them unsuccessful. Wind gusts break apart lesser turbines and none have lasted for an entire winter. IceWind turbines, on the other hand, are engineered to provide reliable power in the most extreme Arctic environments.

The site has a 30W emergency transmitter that needs to run 24 hours a day all year and cannot go off-line. The total power consumption of the system is around 100W. For a vast majority of its lifespan the site has been run on diesel. Solar panels were incorporated in the last ten years to power the station during summer months.

At Straumnes Air Station the wind is known to reach 157 mph – blowing from all directions because of turbulence created by the near-vertical drop on the sides of the mountain the station is on top of. Average wind speed is estimated to be well over 22 mph.

The IceWind Njord turbine installed at Straumnes is made from stainless steel, carbon fiber and aluminum. It will be placed on a concrete platform 26m away from the main power system and will be connected to location’s existing energy system of batteries, solar panels and a diesel engine.

IceWind designs and manufactures robust omni-directional micro vertical-axis wind turbines and other hybrid energy solutions to power telecom towers, and weather and seismic stations, for on-grid and off-grid applications. All products are designed and tested in Iceland, one of the windiest places on earth.

The Njord (RW-series) wind turbines are built to be mounted on commercial towers, and reduce operational costs through an increase in backup power time and reliability, as well as reduced maintenance and failures, minimizing total downtime, and carbon emissions, along with savings from the vastly reduced service and refueling calls needed by diesel generators.

IceWind USA President Daryl Losaw, a USAF veteran, notes, “We are very excited to be working with the Icelandic Coast Guard on this installation and are hopeful that it will be the first of many Arctic region installations of our robust carbon free technology.”

Noted Arctic expert Robert Gerber, the former Acting Deputy Chief of Mission at the US embassy in Reykjavik, and an IceWind advisor, adds, “With our understanding of the power needs in Arctic locations we are thrilled to be part of a critical infrastructure power solution that is also good for the planet.”

Share